Showing results (1961-1970 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|July 22, 2022
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosisRuben Mesa, Claire Harrison, Stephen T Oh, et al.
Leukemia|July 22, 2022
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndromeJ J W M Janssen, B Löwenberg, M Manz, et al.
Leukemia|April 15, 2022
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemiaTheodore W Laetsch, Shannon L Maude, Adriana Balduzzi, et al.
Leukemia|February 4, 2016
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trialA Hochhaus, G Saglio, T P Hughes, et al.
Leukemia|February 6, 2016
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibitionS Köhrer, O Havranek, F Seyfried, et al.
Leukemia|January 1, 2016
Recurrent activating mutations of CD28 in peripheral T-cell lymphomasJ Rohr, S Guo, J Huo, et al.
Leukemia|December 22, 2015
The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cellsE Chang, S Ganguly, T Rajkhowa, et al.
Leukemia|September 1, 1989
The nature of the adherent hemopoietic cells in human long-term bone marrow cultures (HLTBMCs): presence of lymphocytes and plasma cells next to the myelomonocytic populationZ N Berneman, Z Z Chen, D van Bockstaele, et al.
Leukemia|September 1, 1989
A mutant RAS gene acts through protein kinase C to augment interleukin-3 dependent proliferation in a fastidious immortal myeloid cell lineH S Boswell, M A Harrington, G S Burgess, et al.
Leukemia|December 1, 1989
Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-bcr) may be a prognostic indicatorK I Mills, S A Hynds, A K Burnett, et al.
Pageof 963